These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 21953313)

  • 1. Differential effects of nutritional and non-nutritional therapies on intestinal barrier function in an in vitro model.
    Nahidi L; Day AS; Lemberg DA; Leach ST
    J Gastroenterol; 2012 Feb; 47(2):107-17. PubMed ID: 21953313
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adalimumab prevents barrier dysfunction and antagonizes distinct effects of TNF-α on tight junction proteins and signaling pathways in intestinal epithelial cells.
    Fischer A; Gluth M; Pape UF; Wiedenmann B; Theuring F; Baumgart DC
    Am J Physiol Gastrointest Liver Physiol; 2013 Jun; 304(11):G970-9. PubMed ID: 23538493
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular mechanism of tumor necrosis factor-alpha modulation of intestinal epithelial tight junction barrier.
    Ye D; Ma I; Ma TY
    Am J Physiol Gastrointest Liver Physiol; 2006 Mar; 290(3):G496-504. PubMed ID: 16474009
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanism of TNF-{alpha} modulation of Caco-2 intestinal epithelial tight junction barrier: role of myosin light-chain kinase protein expression.
    Ma TY; Boivin MA; Ye D; Pedram A; Said HM
    Am J Physiol Gastrointest Liver Physiol; 2005 Mar; 288(3):G422-30. PubMed ID: 15701621
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA-21 regulates intestinal epithelial tight junction permeability.
    Zhang L; Shen J; Cheng J; Fan X
    Cell Biochem Funct; 2015 Jun; 33(4):235-40. PubMed ID: 25997617
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Total polysaccharides of the Sijunzi decoction attenuate tumor necrosis factor-α-induced damage to the barrier function of a Caco-2 cell monolayer
    Lu Y; Li L; Zhang JW; Zhong XQ; Wei JA; Han L
    World J Gastroenterol; 2018 Jul; 24(26):2867-2877. PubMed ID: 30018481
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor necrosis factor alpha increases epithelial barrier permeability by disrupting tight junctions in Caco-2 cells.
    Cui W; Li LX; Sun CM; Wen Y; Zhou Y; Dong YL; Liu P
    Braz J Med Biol Res; 2010 Apr; 43(4):330-7. PubMed ID: 20445948
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rebeccamycin Attenuates TNF-α-Induced Intestinal Epithelial Barrier Dysfunction by Inhibiting Myosin Light Chain Kinase Production.
    Watari A; Sakamoto Y; Hisaie K; Iwamoto K; Fueta M; Yagi K; Kondoh M
    Cell Physiol Biochem; 2017; 41(5):1924-1934. PubMed ID: 28391269
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protective role of oligomycin against intestinal epithelial barrier dysfunction caused by IFN-γ and TNF-α.
    Liu H; Wang P; Cao M; Li M; Wang F
    Cell Physiol Biochem; 2012; 29(5-6):799-808. PubMed ID: 22613980
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanism of glucocorticoid regulation of the intestinal tight junction barrier.
    Boivin MA; Ye D; Kennedy JC; Al-Sadi R; Shepela C; Ma TY
    Am J Physiol Gastrointest Liver Physiol; 2007 Feb; 292(2):G590-8. PubMed ID: 17068119
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protective role of 1,25(OH)2 vitamin D3 in the mucosal injury and epithelial barrier disruption in DSS-induced acute colitis in mice.
    Zhao H; Zhang H; Wu H; Li H; Liu L; Guo J; Li C; Shih DQ; Zhang X
    BMC Gastroenterol; 2012 May; 12():57. PubMed ID: 22647055
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TNF-alpha-induced increase in intestinal epithelial tight junction permeability requires NF-kappa B activation.
    Ma TY; Iwamoto GK; Hoa NT; Akotia V; Pedram A; Boivin MA; Said HM
    Am J Physiol Gastrointest Liver Physiol; 2004 Mar; 286(3):G367-76. PubMed ID: 14766535
    [TBL] [Abstract][Full Text] [Related]  

  • 13. GLP-2 enhances barrier formation and attenuates TNFα-induced changes in a Caco-2 cell model of the intestinal barrier.
    Moran GW; O'Neill C; McLaughlin JT
    Regul Pept; 2012 Oct; 178(1-3):95-101. PubMed ID: 22809889
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myosin light chain kinase mediates intestinal barrier dysfunction via occludin endocytosis during anoxia/reoxygenation injury.
    Jin Y; Blikslager AT
    Am J Physiol Cell Physiol; 2016 Dec; 311(6):C996-C1004. PubMed ID: 27760753
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential effects of TNF (TNFSF2) and IFN-γ on intestinal epithelial cell morphogenesis and barrier function in three-dimensional culture.
    Juuti-Uusitalo K; Klunder LJ; Sjollema KA; Mackovicova K; Ohgaki R; Hoekstra D; Dekker J; van Ijzendoorn SC
    PLoS One; 2011; 6(8):e22967. PubMed ID: 21853060
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chang'an II Decoction ( II )-Containing Serum Ameliorates Tumor Necrosis Factor-α-Induced Intestinal Epithelial Barrier Dysfunction via MLCK-MLC Signaling Pathway in Rats.
    Chen T; Yin XL; Kang N; Wang XG; Li BS; Ji HJ; Zhang YQ; Bian LQ; Zhang BH; Wang FY; Tang XD
    Chin J Integr Med; 2020 Oct; 26(10):745-753. PubMed ID: 31768870
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hyperresponsiveness of the mucosal barrier in Crohn's disease is not tumor necrosis factor-dependent.
    Suenaert P; Bulteel V; Vermeire S; Noman M; Van Assche G; Rutgeerts P
    Inflamm Bowel Dis; 2005 Jul; 11(7):667-73. PubMed ID: 15973122
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metformin regulates tight junction of intestinal epithelial cells via MLCK-MLC signaling pathway.
    Zhou HY; Zhu H; Yao XM; Qian JP; Yang J; Pan XD; Chen XD
    Eur Rev Med Pharmacol Sci; 2017 Nov; 21(22):5239-5246. PubMed ID: 29228440
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-TNF-α antibodies improve intestinal barrier function in Crohn's disease.
    Noth R; Stüber E; Häsler R; Nikolaus S; Kühbacher T; Hampe J; Bewig B; Schreiber S; Arlt A
    J Crohns Colitis; 2012 May; 6(4):464-9. PubMed ID: 22398062
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-TNF Therapy Induces CD4+ T-Cell Production of IL-22 and Promotes Epithelial Repairs in Patients With Crohn's Disease.
    Fang L; Pang Z; Shu W; Wu W; Sun M; Cong Y; Liu Z
    Inflamm Bowel Dis; 2018 Jul; 24(8):1733-1744. PubMed ID: 29718341
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.